ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2500

Suicidal Ideation and Self-Efficacy in Systemic Lupus Erythematosus: Georgians Organized Against Lupus (GOAL) Cohort

Charmayne Dunlop-Thomas1, Gaobin Bao1, Jessica Williams2, Hilton Mozee1, Cristina Drenkard1 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA

Meeting: ACR Convergence 2023

Keywords: mental health, Patient reported outcomes, psychosocial factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Interprofessional OA & Lupus

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Suicidal ideation is more common in SLE than in other chronic diseases. Targeted interventions are needed to reduce morbidity and mortality. Bandura’s theory of self-efficacy notes the importance of individual perception of capabilities as predictors of health and well-being. Patients working with healthcare professionals to understand and manage symptoms is crucial. This study aimed to identify health and psychosocial factors associated with SI among patients with SLE, which could serve as possible targets for intervention by healthcare professionals. We explored the possible association between self-efficacy (SE) for managing symptoms and treatments and suicidal ideation (SI) among SLE patients from the Georgians Organized Against Lupus (GOAL) Cohort.

Methods: We examined data from the GOAL Cohort, a large population-based cohort of adults from metropolitan Atlanta, Georgia, who fulfilled three or more ACR classification criteria with a final SLE diagnosis by a board-certified rheumatologist. GOAL participants responded to validated self-administered tools on health outcomes. This study included participants with completed surveys between 2017- 2020. We explored the following measures: Patient Health Questionnaire-9, PROMIS Self-efficacy for managing medications and treatments (SEMMT) and PROMIS Self-efficacy for managing symptoms (SEMS), PROMIS depression, the Systemic Lupus Activity Questionnaire (SLAQ), and the Self-administered Brief Index of Lupus Damage (SA-BILD). We examined an individual SEMS question for further examination: I can work with my doctor to manage my symptoms with response choices on a Likert scale from 1 (I am not at all confident) to 5 (I am very confident). Logistic regression was used to examine factors associated with SI.

Results: This study includes data from 967 SLE participants (94% women, mean age 32 years [SD 11.8], 82% Black, mean disease duration 15 years [SD 10.3], 14% uninsured). The mean disease activity and organ damage scores were 15 (SD 8.8) and 4 (SD 3.7), respectively. The t-scores for SEMMT and SEMS were 46 [SD 8.9] and 48 [SD 8.7], respectively. Ninety participants (9.4%) endorsed suicidal ideation.

Univariate analyses showed that lower SE, higher SLE activity and higher depression scores were significantly associated with SI. In the multivariate analysis, only lower SE related to working with doctors to manage symptoms remained significantly associated with suicidal ideation after controlling for other factors (Table).

Conclusion: In a population-based, predominantly Black SLE cohort with considerable disease activity, there was a significant proportion of suicidal ideation. After controlling for other risk factors, such as socio-demographics and disease status, those with low self-efficacy for working with doctors to manage symptoms were at higher risk for SI. Health professionals can consider assessing and addressing perceptions of self-management capabilities among patients with SLE in order to improve outcomes in this vulnerable population.

Supporting image 1


Disclosures: C. Dunlop-Thomas: None; G. Bao: None; J. Williams: None; H. Mozee: None; C. Drenkard: None; S. Lim: None.

To cite this abstract in AMA style:

Dunlop-Thomas C, Bao G, Williams J, Mozee H, Drenkard C, Lim S. Suicidal Ideation and Self-Efficacy in Systemic Lupus Erythematosus: Georgians Organized Against Lupus (GOAL) Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/suicidal-ideation-and-self-efficacy-in-systemic-lupus-erythematosus-georgians-organized-against-lupus-goal-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/suicidal-ideation-and-self-efficacy-in-systemic-lupus-erythematosus-georgians-organized-against-lupus-goal-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology